Maeva Y. Chauvin

This study identifies cancer-associated mesothelial cells (CAMCs) as drivers of immune escape and therapy resistance in ovarian cancer by altering immune cell infiltration and function.

This study identifies FSTL3 as a biomarker of poor prognosis and immunotherapy resistance in ovarian cancer, showing its role in promoting a mesenchymal phenotype and immunosuppressive microenvironment.

This study uses scRNA-seq to investigate how AMH protects ovarian cells from doxorubicin toxicity by modulating cell fate and DNA repair mechanisms in different ovarian cell types.

The paper identifies a higher density of CD73+ γδ T cells in ovarian cancer tumors from patients with poor survival, describing their pro-tumor ecosystem.

This study constructs a single-cell atlas of the murine ovary by analyzing >34,000 cells across the estrous cycle to characterize cell state dynamics and transcriptional changes.